SLAM (E-11) Antibody sc-166939 from Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

(1) SLAMF1 is expressed and secreted by hepatocytes and the liver in nonalcoholic fatty liver diseaseAmerican journal of physiology. Gastrointestinal and liver physiologySeptember 1, 2022Gomez-Torres O, Amatya S, Kamberov L, Dhaibar HA, Khanna P, Rom O, Yurdagul A Jr, Orr AW, Nunez K, Thevenot P, et al.

(2) Repository corticotrophin injection exerts direct acute effects on human B cell gene expression distinct from the actions of glucocorticoidsClinical and experimental immunologyApril 1, 2018Benko AL, McAloose CA, Becker PM, Wright D, Sunyer T, Kawasawa YI, Olsen NJ, Kovacs WJ.

(3) Elevated SAP/SLAM expression in hepatitis B vaccine responders, but not in non-responders among chronic hepatitis C patientsBiomedical ResearchJanuary 1, 2018Jian Fu, Xuejiao Pan, Jun Yao, Shuyun Xie, Huakun Lv, Zhifang Wang, Chonggao Hutemperature and incubated with primary and secondary antibodies. Monoclonal antibodies against CD150 (sc-166939, Santa Cruz Biotechnology) and SH2D1A (sc-398118, Santa Cruz Biotechnology) were used at a dilution

SLAM (E-11) Antibody